SOAT1 and neoplasm: AZD1480, Stattic, and WP1066 represent JAK/STAT inhibitors commonly used; in particular, AZD1480 has been shown to exhibit specific activity against Jak2 kinase, mitigating tumor cell proliferation in a variety of solid tumors23.